Wealthspire Advisors, LLC Cardiol Therapeutics Inc. Transaction History
Wealthspire Advisors, LLC
- $17.6 Billion
- Q2 2025
A detailed history of Wealthspire Advisors, LLC transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Wealthspire Advisors, LLC holds 15,151 shares of CRDL stock, worth $16,060. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,151
Previous 15,151
-0.0%
Holding current value
$16,060
Previous $14,000
42.86%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CRDL
# of Institutions
42Shares Held
6.56MCall Options Held
37.6KPut Options Held
0-
Tejara Capital LTD London, X03.27MShares$3.46 Million2.06% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD857KShares$908,8310.22% of portfolio
-
Lion Street Advisors, LLC340KShares$360,4260.15% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9293KShares$310,6390.15% of portfolio
-
Pvg Asset Management Corp Golden, CO283KShares$300,4801.46% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $65.7M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...